ArticleCancer immunology, immunotherapy : CII2018

Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression.

Jonathan P O Hebb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.